factmr report

Home Diagnostics Market Spurs on the Back of Self-diagnosis Preference

Increasing preference for self-diagnosis continues to be a catalyst for sales of home diagnostics, although the strategies of market players continue to be affected by a combination of industry-specific and regulatory factors. Such governing bodies as the United States With strict quality management standards and labeling requirements, the Food and Drug Administration (FDA) and the European Commission govern home diagnostics. The acquisition of the EU CE label, FDA 510(k) approval and FDA approved Premarket Approval Application (PMA) continues to be a primary focus for manufacturers of home diagnostics who are looking to scale up their presence in developed markets.

Increased understanding of health has accelerated customer acceptance of personalized drugs and home diagnostics. Sensing the requirements of end-users, market players in home diagnostics concentrate on improving performance, precision, reliability, and convenience. Investments in the development of home diagnostics have invariably changed to the implementation of advanced technology. Market players are working on improving the performance characteristics of home diagnostics by incorporating wearable devices, the Internet of Things (IoT), and Artificial Intelligence (AI).

The rising prevalence of diabetes worldwide and the growing need to track sugar levels among diabetes patients are likely to improve the adoption of glucose monitoring devices. Fact.MR projects market players in home diagnostics are aware of the growing demand for glucose monitoring devices and are concentrating on increasing their portfolio of products in this segment. In the home diagnostics industry, the other lucrative segments include pregnancy tests and kits for ovulation prediction.

Growing emphasis on R&D customers, developing countries are witnessing increasing adoption of advanced technologies to develop highly efficient home diagnostics, and are becoming more aware of the availability of home diagnostics that will enable them to perform in vitro diagnostic tests at home without the need for professional assistance. However, in developing nations, especially in Asia and the Middle East & Africa, lower health awareness is limiting the adoption of home diagnostics